Civic AI
Procurement intelligence
Federal contract award
FG-2101: A FIRST-IN-CLASS LPXC INHIBITOR FOR THE TREATMENT OF MDR GRAMNEGATIVE URINARY TRACT INFECTIONS.
BLACKSMITH MEDICINES, INC. · Department of Health and Human Services
- Value
- $12,132,070
- Start
- Sep 21, 2022
- End
- Dec 31, 2026
- Action date
- Apr 9, 2026
- PIID
- 75N93022C00060
- Status
- active
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- SAN DIEGO, CA
- Award type
- DEFINITIVE CONTRACT
Description
FG-2101: A FIRST-IN-CLASS LPXC INHIBITOR FOR THE TREATMENT OF MDR GRAMNEGATIVE URINARY TRACT INFECTIONS.
Need modifications, related awards, and vendor peers? Open the full award workspace.